Tenaya Therapeutics (TNYA) said late Monday it priced an underwritten public offering of 75 million units at $0.70 per unit for gross proceeds of $52.5 million.
Each unit consists of one common share, one warrant to purchase one common share at an exercise price of $0.80 per share, and one warrant to purchase one-half of a common share at an exercise price of $0.70 per share.
Net proceeds will be used to fund clinical development activities, working capital and general corporate purposes, the company said.
Closing of the offering is expected on or about Wednesday, subject to customary conditions.
Tenaya Therapeutics shares fell more than 27% in after-hours activity Monday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.